Brussels, 07/01/2002 (Agence Europe) - In a press release, the High Level Group for Life Sciences, created at the initiative of Commissioner Philippe Busquin and chaired by Professor Axel Kahn, acknowledges that the use of human stem cells in regenerative medicine is still at a very early stage of development, but considers that it opens the way to real progress for the treatment of various serious illnesses. The Group mainly notes that: (1) The EU should keep up its support for research on...